K. Berneis et al., EFFECTS OF GLUCOCORTICOIDS AND OF GROWTH-HORMONE ON SERUM LEPTIN CONCENTRATIONS IN MAN, European journal of endocrinology, 135(6), 1996, pp. 663-665
Recent data suggest an involvement of the ob gene and its product lept
in in the regulation of body fat. To assess the effects of glucocortic
oids and growth hormone (GH) on serum leptin and body fat, 30 normal s
ubjects received methylprednisolone (0.5 mg . kg(-1) day(-1)) per os f
or 7 days and 15 subjects received in addition sc injections of GH (0.
15 IU . kg(-1) day(-1)) twice daily (combination group). Serum leptin
levels increased both in the glucocorticoid group (p < 0.02) and in th
e combination group (p < 0.002). When body fat was estimated by bioele
ctrical impedance analysis it decreased during combined treatment and
remained unchanged in the glucocorticoid group. Plasma insulin concent
rations increased in both groups. Resting energy expenditure (indirect
calorimetry) increased in the combination group and remained unchange
d in the glucocorticoid group. The finding of increased serum leptin c
oncentrations during treatment with glucocorticoid and GH suggests tha
t serum leptin is regulated by glucocorticoids, possibly though change
s in insulin secretion, independently of changes of body fat mass.